CLINICAL-PHARMACOLOGICAL VALUE OF TREATMENT EFFICIENCY OF BHP-PATIENTS BY ANTITHROMBOTIC THERAPY
Patients with BHP need in pharmacological treatment of thrombosis the most often in the first 3 cases because has dysfunctions of platelets and coagulation. According to results of analysis of efficiency antithrombotic therapy in BHP-patients confirmed clinical and biochemical influence antithrombot...
Main Authors: | A.A. Svistunov, P.V. Glybochko, M.V. Soldatenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Saratov State Medical University
2007-09-01
|
Series: | Саратовский научно-медицинский журнал |
Subjects: | |
Online Access: | http://www.ssmj.ru/system/files/200703_091.pdf |
Similar Items
-
Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer
by: Tokiwa S, et al.
Published: (2017-12-01) -
Continued administration of antithrombotic agents during transperineal prostate biopsy
by: Toko Asano, et al.
Published: (2015-02-01) -
Neuroendocrine aspects of prostate oncogenesis
by: P.V. Glybochko, et al.
Published: (2010-03-01) -
Clinical and prognostic value of the cystostomy in patients with prostate cancer after combined treatment
by: S. A. Sidorova, et al.
Published: (2015-09-01) -
CLINICAL PHARMACOLOGY OF DIURETICS
by: I. V. Soldatenko
Published: (2014-06-01)